Porton Pharma Solutions Ltd. (SHE:300363)
24.72
+0.12 (0.49%)
Oct 21, 2025, 2:47 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 13.34 billion as of October 21, 2025. Its market cap has increased by 108.99% in one year.
Market Cap
13.34B
Enterprise Value
13.95B
Revenue
3.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
24.72
Market Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 13.34B, an increase of 238.49%. That is a compound annual growth rate of 10.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 20, 2025 | 13.34B | 55.05% |
Dec 31, 2024 | 8.60B | -37.37% |
Dec 29, 2023 | 13.73B | -38.42% |
Dec 30, 2022 | 22.31B | -54.20% |
Dec 31, 2021 | 48.70B | 145.68% |
Dec 31, 2020 | 19.82B | 155.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 433.20B |
WuXi AppTec | 284.61B |
Shenzhen Mindray Bio-Medical Electronics | 272.72B |
Sichuan Biokin Pharmaceutical | 142.05B |
Zhangzhou Pientzehuang Pharmaceutical., | 118.46B |
Shanghai United Imaging Healthcare | 117.99B |
Aier Eye Hospital Group | 116.66B |
Yunnan Baiyao Group Co.,Ltd | 101.81B |